UroCareLive

CME Presentations

Bladder Cancer


Presentations

  • CME
    1.0

    New Horizons in Personalized Care for Metastatic Bladder Cancer

    Speakers:Matthew I. Milowsky, MD, Section Chief, Genitourinary Oncology
    Matthew Galsky, MD, Director of Genitourinary Medical Oncology

    Duration: 60 minutes

    Presented on: August 11, 2017


Speakers

  • Matthew I. Milowsky, MD

    Matthew I. Milowsky, MD

    Matthew I. Milowsky, MD

    Section Chief, Genitourinary Oncology

    Matthew I. Milowsky, MD, is section chief of the Genitourinary Oncology Service and co-director of the Urologic Oncology Program at the University of North Carolina (UNC) at Chapel Hill Lineberger Comprehensive Cancer Center. He leads the Genitourinary Oncology Research Program, which focuses on translational science and clinical trials for patients with urologic cancers. Dr Milowsky is also the clinic medical director at North Carolina Cancer Hospital, where he serves as a member of the Executive Committee and co-chair of the Operations Committee. He has published extensively in peer-reviewed journals, written several book chapters, and was principal investigator on the American Association for Cancer Research Henry Shepard Grant for Bladder Cancer Research.
  • Matthew Galsky, MD

    Matthew Galsky, MD

    Matthew Galsky, MD

    Director of Genitourinary Medical Oncology

    Matthew Galsky, MD, is the director of genitourinary medical oncology at the Mount Sinai School of Medicine Tisch Cancer Institute in New York. Dr Galsky specializes in caring for patients with genitourinary malignancies (bladder, prostate, kidney, and testicular cancers). His research focuses on the clinical development of novel therapies for genitourinary cancers, with a particular emphasis on bladder cancer, and he regularly speaks nationally and internationally on the topic. His research has been published in numerous journals, including the Journal of Clinical Oncology, Journal of the National Cancer Institute, Lancet Oncology and Lancet, and has been funded by organizations that include the National Institutes of Health/National Cancer Institute and the Department of Defense.

CME Information